Monoclonal Antibody Generation
Monoclonal Antibody Generation - Related Videos
13:21
Antibody Generation: Producing Monoclonal Antibodies Using Hybridomas
0 Views •
2023
Source: Frances V. Sjaastad1,2, Whitney Swanson2,3, and Thomas S. Griffith1,2,3,4 1 Microbiology, Immunology, and Cancer Biology Graduate Program, University of Minnesota, Minneapolis, MN 55455 2 Center for Immunology, University of Minnesota, Minneapolis, MN 55455 3 Department of Urology, University of Minnesota, Minneapolis, MN 55455 4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455 Polyclonal antibodies are defined as a collection of antibodies directed against...
07:55
Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
0 Views •
Cited by 10 •
2017
We describe a method by which we identify critical residues required for the binding of human or murine monoclonal antibodies that target the viral hemagglutinin of influenza A viruses. The protocol can be adapted to other virus surface glycoproteins and their corresponding neutralizing antibodies.
12:15
Generation of Monoclonal Antibodies Against Natural Products
0 Views •
Cited by 2 •
2019
This article provides a detailed protocol for the preparation and evaluation of monoclonal antibodies against natural products for use in various immunoassays. This procedure includes immunization, cell fusion, indirect competitive ELISA for positive clone screening, and monoclonal hybridoma preparation. The specifications for antibody characterization using MALDI-TOF-MS and ELISA analyses are also provided.
10:32
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
0 Views •
Cited by 7 •
2015
Synthesis of human monoclonal antibodies is the first step in studies aimed at unraveling the pathophysiological mechanisms of auto-antibody-mediated immune responses. We have developed a protocol to generate recombinant human immunoglobulin G (IgG) monoclonal antibodies from blood sorted B cells, including B-cell isolation, antibody cloning and in vitro synthesis.
02:10
Generating Recombinant Monoclonal Antibodies From Mammalian Cell Cultures
0 Views •
2025
This video demonstrates a method of antibody generation from mammalian cells by introducing plasmid vectors with heavy and light chain genes. These vectors interact with polyethylenimine and enter the cells by forming polyplexes; later, they are translated into individual proteins and assembled into complete antibodies, which are secreted into the extracellular medium.
FAQs
Myeloma cells provide an immortal cellular partner for antibody-producing B cells, allowing the fused hybridoma to persist in culture and secrete antibody. Selection in culture helps enrich for successfully fused cells before individual clones undergo specificity screening. This combination links the B cell’s antibody production capacity with sustained growth, making it possible to recover stable antibody-secreting clones.
Binding to a single epitope gives a monoclonal antibody a defined molecular target, which supports precise detection and localization of an antigen. During screening, researchers identify clones with the desired specificity rather than selecting only for antibody secretion. This distinction matters when comparing antigens, tracking pathogen components, or testing whether antibody binding influences a defined immune or infectious process.
Recombinant methods allow antibody genes to be engineered and expressed in selected systems after an antibody sequence or clone has been identified. This creates opportunities to optimize binding, stability, or biological activity beyond the properties of the original antibody-producing cell. Such modifications can help adapt an antibody for experimental studies, diagnostic development, or targeted therapeutic investigation.
A classic workflow begins with immunization, followed by isolation of antibody-producing B cells and fusion with immortal myeloma cells. The resulting cells are selected in culture, screened for antigen specificity, and expanded when the desired clone is identified. The expanded clone then supplies antibody for downstream studies, providing a defined and renewable source for repeated experiments.
These antibodies support pathogen detection, antigen localization, and neutralization studies. They can reveal where an antigen occurs, test whether antibody binding affects infectious targets, and contribute to diagnostic development. Because each preparation recognizes a defined epitope, researchers can use it as a controlled reagent when examining immune responses or investigating interactions between host components and pathogens.
A selected clone provides a consistent antibody reagent with a defined target, reducing variability when researchers compare samples or repeat experiments. In infection research, that consistency supports analyses of pathogen antigens, their distribution, and antibody-mediated neutralization. The same principle also helps connect observations from antigen localization or detection assays with broader studies of immune control and pathogen behavior.